NCT04150861View on ClinicalTrials.gov

Rekovelle PK Trial in Chinese Women

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 23, 2019

Primary Completion Date

November 28, 2019

Study Completion Date

December 16, 2019

Conditions
Infertility
Interventions
DRUG

Follitropin Delta

Solution for Injection, subcutaneous administration

Trial Locations (1)

Unknown

First Hospital Affiliated to Nanjing Medical University Jiangsu Province Hospital, Nanjing

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT04150861 - Rekovelle PK Trial in Chinese Women | Biotech Hunter | Biotech Hunter